Circulation. 2008;118:1113-1114
doi: 10.1161/CIRCULATIONAHA.108.190525
(Circulation. 2008;118:1113-1114.)
© 2008 American Heart Association, Inc.
Clinical Summaries
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Dynamic Mechanism for Initiation of Ventricular Fibrillation In Vivo
|
|---|
Our study demonstrates a novel mechanism of induction of ventricular
fibrillation in vivo in intact normal beagle dogs. This work
may contribute to our understanding of the mechanisms leading
to the development of ventricular fibrillation in the structurally
normal heart. For example, in patients with idiopathic ventricular
fibrillation, focal ectopic ventricular activity originating
in the Purkinje network is thought to trigger the onset of ventricular
fibrillation. Our work also may be clinically relevant to patients
with channelopathies, ie, long-QT syndrome, in which typically
a short-long-short sequence of premature stimuli induces ventricular
tachycardia and fibrillation. We showed in our study that such
specific patterns (called CL
VF, cycle lengths inducing VF) can
indeed lead to ventricular fibrillation by creating conduction
block and wave break, depending on the restitution properties
of the action potential duration and conduction velocity. In
that regard, a potential therapeutic application of our work
is to specifically target the restitution parameters with drugs
so that CL
VF would no longer lead to ventricular fibrillation.
We showed that the calcium channel blocker verapamil exerts
antifibrillatory effects by altering restitution parameters
but not at clinically relevant dosages. However, we postulate
that other drugs may prove to have antiarrhythmic effects by
altering the restitution parameters of a patient and thus may
prevent the induction of ventricular fibrillation rather than
by suppressing the premature stimuli. See p 1123.
 |
Longitudinal Strain Delay Index by Speckle Tracking Imaging: A New Marker of Response to Cardiac Resynchronization Therapy
|
|---|
Recent results from the PROSPECT and RETHINQ trials might suggest
that a relatively limited and simple quantification of left
ventricular dyssynchrony has suboptimal accuracy
. . . [Full Text of this Article]
Related Articles:
-
Dynamic Mechanism for Initiation of Ventricular Fibrillation In Vivo
- Anna R.M. Gelzer, Marcus L. Koller, Niels F. Otani, Jeffrey J. Fox, Michael W. Enyeart, Giles J. Hooker, Mark L. Riccio, Carlo R. Bartoli, and Robert F. Gilmour, Jr
Circulation 2008 118: 1123-1129.
[Abstract]
[Full Text]
-
Longitudinal Strain Delay Index by Speckle Tracking Imaging: A New Marker of Response to Cardiac Resynchronization Therapy
- Pascal Lim, Adisai Buakhamsri, Zoran B. Popovic, Neil L. Greenberg, Dimpi Patel, James D. Thomas, and Richard A. Grimm
Circulation 2008 118: 1130-1137.
[Abstract]
[Full Text]
-
Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials
- Joost Daemen, Eric Boersma, Marcus Flather, Jean Booth, Rod Stables, Alfredo Rodriguez, Gaston Rodriguez-Granillo, Whady A. Hueb, Pedro A. Lemos, and Patrick W. Serruys
Circulation 2008 118: 1146-1154.
[Abstract]
[Full Text]
-
Drug-Eluting Versus Bare Metal Stents in Patients With ST-Segment–Elevation Myocardial Infarction: Eight-Month Follow-Up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) Trial
- Henning Kelbæk, Leif Thuesen, Steffen Helqvist, Peter Clemmensen, Lene Kløvgaard, Anne Kaltoft, Bente Andersen, Helle Thuesen, Thomas Engstrøm, Hans E. Bøtker, Kari Saunamäki, Lars R. Krusell, Erik Jørgensen, Hans-Henrik T. Hansen, Evald H. Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian J. Terkelsen, Jens F. Lassen for the DEDICATION Investigators
Circulation 2008 118: 1155-1162.
[Abstract]
[Full Text]
-
Fhl-1, a New Key Protein in Pulmonary Hypertension
- Grazyna Kwapiszewska, Malgorzata Wygrecka, Leigh M. Marsh, Sigrid Schmitt, Roger Trösser, Jochen Wilhelm, Katja Helmus, Bastian Eul, Anna Zakrzewicz, Hossein A. Ghofrani, Ralph T. Schermuly, Rainer M. Bohle, Friedrich Grimminger, Werner Seeger, Oliver Eickelberg, Ludger Fink, and Norbert Weissmann
Circulation 2008 118: 1183-1194.
[Abstract]
[Full Text]
-
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque
- Patrick W. Serruys, Héctor M. García-García, Pawel Buszman, Paul Erne, Stefan Verheye, Michael Aschermann, Henrikus Duckers, Oyvind Bleie, Dariusz Dudek, Hans Erik Bøtker, Clemens von Birgelen, Don D'Amico, Tammy Hutchinson, Andrew Zambanini, Frits Mastik, Gerrit-Anne van Es, Antonius F.W. van der Steen, D. Geoffrey Vince, Peter Ganz, Christian W. Hamm, William Wijns, Andrew Zalewski for the Integrated Biomarker and Imaging Study-2 Investigators
Circulation 2008 118: 1172-1182.
[Abstract]
[Full Text]
-
Impact of In-Hospital Revascularization on Survival in Patients With Non–ST-Elevation Acute Coronary Syndrome and Congestive Heart Failure
- Philippe Gabriel Steg, Arthur Kerner, Frans Van de Werf, José López-Sendón, Joel M. Gore, Gordon FitzGerald, Laurent J. Feldman, Frederick A. Anderson, Álvaro Avezum for the Global Registry of Acute Coronary Events (GRACE) Investigators
Circulation 2008 118: 1163-1171.
[Abstract]
[Full Text]